China Universal Asset Management Company’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$264K Buy
2025
Q1
$319K Sell
2024
Q4
$317K Buy
2024
Q3
$206K Buy
2024
Q2
$73.5K Sell
2024
Q1
$113K Buy
2023
Q4
$78.1K Buy
2023
Q3
$17.1K Buy
2023
Q2
$15K Buy
2023
Q1
$19.7K Buy
2022
Q4
$13.7K Buy
2022
Q3
$15K Buy